Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Dhanvantri Jeevan Rekha's FCF Yield % or its related term are showing as below:
BOM:531043'
s FCF Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 7.8
Current: 7.8
During the past 13 years, the highest FCF Yield % of Dhanvantri Jeevan Rekha was 7.80%. The lowest was 0.00%. And the median was 0.00%.
BOM:531043's FCF Yield % is ranked better than 77.05% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 1.82
vs BOM:531043: 7.80
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Dhanvantri Jeevan Rekha FCF Yield % Related Terms
Dhanvantri Jeevan Rekha FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:531043 vs HCA, THC, DVA: FCF Yield % Comparison
For the Medical Care Facilities subindustry, Dhanvantri Jeevan Rekha's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dhanvantri Jeevan Rekha FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dhanvantri Jeevan Rekha's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Dhanvantri Jeevan Rekha's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dhanvantri Jeevan Rekha (BOM:531043) has a FCF Yield % of 7.80 as of Jul. 14, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Dhanvantri Jeevan Rekha and its competitors. According to the industry distribution chart, Dhanvantri Jeevan Rekha ranks #157 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 23%.
Is Dhanvantri Jeevan Rekha's FCF Yield % too high?
Dhanvantri Jeevan Rekha's current FCF Yield % is 7.80. The Healthcare Providers & Services industry median FCF Yield % is 1.82. Dhanvantri Jeevan Rekha's value of 7.80 is 328.6% above this industry median. Based on the distribution chart, Dhanvantri Jeevan Rekha ranks #157 out of 684 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dhanvantri Jeevan Rekha has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dhanvantri Jeevan Rekha's FCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dhanvantri Jeevan Rekha ranks #157 out of 684 companies for FCF Yield %. This places Dhanvantri Jeevan Rekha in the top 23% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.82. Dhanvantri Jeevan Rekha's value of 7.80 is 328.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.82, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dhanvantri Jeevan Rekha's current FCF Yield % of 7.80 is 328.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Dhanvantri Jeevan Rekha and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dhanvantri Jeevan Rekha's current FCF Yield % is 7.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dhanvantri Jeevan Rekha stock overvalued right now?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha (BOM:531043) is currently considered Fairly Valued. The stock's GF Value™ is ₹24.96, compared to a current price of ₹27.40 — trading 9.8% above its estimated fair value. The current FCF Yield % is 7.80 and 328.6% above the Healthcare Providers & Services industry median of 1.82. Dhanvantri Jeevan Rekha's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Dhanvantri Jeevan Rekha (BOM:531043), the current FCF Yield % is 7.80 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dhanvantri Jeevan Rekha (BOM:531043) Overvalued in 2026?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha stock appears to be overvalued.
The current stock price of ₹27.40 is trading 9.8% above its estimated GF Value™ of ₹24.96.
GuruFocus considers Dhanvantri Jeevan Rekha to be Fairly Valued.
Key valuation signals for BOM:531043:
FCF Yield %: 7.80
GF Value™: ₹24.96 vs. price of ₹27.40 (9.8% above fair value)
Industry Position: 328.6% above the Healthcare Providers & Services median (#157 of 684)
No single metric tells the full story. See the BOM:531043 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dhanvantri Jeevan Rekha Ltd is engaged in providing diagnostic and therapeutic services and has extended its scope of diagnostic and hospital services by providing a fully operational Cath Lab, catering to higher end needs of the cardiac patients including Angiography, Angioplasty, Pacemaker Implantation, Valvuloplasty etc. The hospital has expanded its services to include a wide range of specialties such as Cardiology, Neurology, Orthopedics, Radiology, Gastroenterology, General Surgery, Urology, and General Medicine.
63GF Score
Get the complete analysis for BOM:531043
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531043 has been successfully added to your 
